230 related articles for article (PubMed ID: 25212663)
1. Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic review.
Previti G; Pawlby S; Chowdhury S; Aguglia E; Pariante CM
Arch Womens Ment Health; 2014 Dec; 17(6):471-83. PubMed ID: 25212663
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental outcome of premature infants after exposure to antenatal indomethacin.
Amin SB; Kamaluddeen M; Sangem M
Am J Obstet Gynecol; 2008 Jul; 199(1):41.e1-8. PubMed ID: 18455131
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review.
Gentile S; Galbally M
J Affect Disord; 2011 Jan; 128(1-2):1-9. PubMed ID: 20303599
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure.
Shankaran S; Papile LA; Wright LL; Ehrenkranz RA; Mele L; Lemons JA; Korones SB; Stevenson DK; Donovan EF; Stoll BJ; Fanaroff AA; Oh W; Verter J
Am J Obstet Gynecol; 2002 Jul; 187(1):171-7. PubMed ID: 12114906
[TBL] [Abstract][Full Text] [Related]
5. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.
Makrides M; Gibson RA; McPhee AJ; Yelland L; Quinlivan J; Ryan P;
JAMA; 2010 Oct; 304(15):1675-83. PubMed ID: 20959577
[TBL] [Abstract][Full Text] [Related]
6. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
Lewis AJ; Galbally M; Opie G; Buist A
Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period.
McDonagh M; Matthews A; Phillipi C; Romm J; Peterson K; Thakurta S; Guise JM
Evid Rep Technol Assess (Full Rep); 2014 Jul; (216):1-308. PubMed ID: 30313002
[TBL] [Abstract][Full Text] [Related]
10. Developmental outcomes of children exposed to antidepressants in pregnancy.
Galbally M; Lewis AJ; Buist A
Aust N Z J Psychiatry; 2011 May; 45(5):393-9. PubMed ID: 21314237
[TBL] [Abstract][Full Text] [Related]
11. Breastfeeding and antidepressants.
Field T
Infant Behav Dev; 2008 Sep; 31(3):481-7. PubMed ID: 18272227
[TBL] [Abstract][Full Text] [Related]
12. Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature.
Suri R; Lin AS; Cohen LS; Altshuler LL
J Clin Psychiatry; 2014 Oct; 75(10):e1142-52. PubMed ID: 25373125
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Effects of Intrauterine Exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes: A Systematic Review.
Rommel AS; Bergink V; Liu X; Munk-Olsen T; Molenaar NM
J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32412703
[TBL] [Abstract][Full Text] [Related]
14. Prenatal antipsychotic exposure and neuromotor performance during infancy.
Johnson KC; LaPrairie JL; Brennan PA; Stowe ZN; Newport DJ
Arch Gen Psychiatry; 2012 Aug; 69(8):787-94. PubMed ID: 22474072
[TBL] [Abstract][Full Text] [Related]
15. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
Hanley GE; Brain U; Oberlander TF
Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Independent and Joint Effects of Unmedicated Prenatal Depressive Symptoms and Alcohol Consumption in Pregnancy and Infant Neurodevelopmental Outcomes.
Bandoli G; Coles CD; Kable JA; Wertelecki W; Granovska IV; Pashtepa AO; Chambers CD;
Alcohol Clin Exp Res; 2016 Jun; 40(6):1304-11. PubMed ID: 27129610
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants for preventing postnatal depression.
Molyneaux E; Telesia LA; Henshaw C; Boath E; Bradley E; Howard LM
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD004363. PubMed ID: 29669175
[TBL] [Abstract][Full Text] [Related]
18. The mothers, Omega-3 and mental health study.
Mozurkewich E; Chilimigras J; Klemens C; Keeton K; Allbaugh L; Hamilton S; Berman D; Vazquez D; Marcus S; Djuric Z; Vahratian A
BMC Pregnancy Childbirth; 2011 Jun; 11():46. PubMed ID: 21696635
[TBL] [Abstract][Full Text] [Related]
19. MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero.
Heinonen E; Szymanska-von Schultz B; Kaldo V; Nasiell J; Andersson E; Bergmark M; Blomdahl-Wetterholm M; Forsberg L; Forsell E; Forsgren A; Frööjd S; Goldman A; Nordenadler EM; Sklivanioti M; Blennow M; Wide K; Gustafsson LL
BMJ Open; 2018 Aug; 8(8):e023281. PubMed ID: 30082365
[TBL] [Abstract][Full Text] [Related]
20. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
